Group Account Supervisor - Market Access & Payer
About the job
- A minimum of 5 years of progressive account management experience in market access, payer marketing, or related healthcare communications.
- Demonstrated experience developing payer strategies, access materials, and reimbursement-focused campaigns.
- A bachelor's degree is required.
- Lead the day-to-day client relationship with a focus on market access and payer strategy, ensuring all deliverables align with brand objectives, access goals, and evolving reimbursement dynamics.
- Partner closely with Medical, Strategy, and Creative leadership to develop compelling payer evidence-based communications.
- Maintain fiscal oversight, including scope management, staffing alignment, and budget accountability across access-focused initiatives.
- Serve as a trusted advisor to clients, identifying opportunities to optimize market access, strengthen customer engagement, and expand account growth.
- Lead development of key access marketing assets such as value propositions, websites, and reimbursement support tools.
- Mentor and develop Account team members, fostering expertise in market access, payer dynamics, and strategic account management.
- Support a high-performance, collaborative team culture rooted in accountability, innovation, and growth.
- Participate in client-related travel as required, including local and domestic travel.
- Experience across multiple products, therapeutic areas, and payer segments, including commercial, Medicare, and Medicaid.
- Experience managing direct reports.
About the company
BGBx is a healthcare consultancy that helps pharmaceutical, biotech, and medical device companies turn scientific advances into practical, credible brand stories and strategies. Its services include medical communications to explain science clearly, market access planning to help products reach patients, and payer strategy to work with insurance decision-makers. The work is done by a team that combines clinical knowledge, academic insight, and industry experience, and is delivered through project-based engagements that aim for real-time, real-world impact. Unlike firms that rely on generic marketing, BGBx differentiates itself with a strong, multidisciplinary medical team and a clear focus on translating science into strategies that improve access and outcomes. The company’s goal is to help clients communicate complex science effectively while shaping reimbursement and market access to bring new therapies and devices to patients more efficiently.
Company Size
501-1,000
Company Stage
N/A
Total Funding
N/A
Headquarters
New York City, New York
Founded
2014
Get referred to BGBx
See people who can refer or advise you
Simplify's Take
What believers are saying
- June 2026 BGBx rebrand signals broader commercial scope and stronger cross-sell opportunities.
- Greenhouse listed 17 open roles in September 2026, showing active hiring.
- The 2023 Kx Advisors acquisition expanded strategy consulting across biopharma and medical devices.
What critics are saying
- BGBx still depends on pharma marketing budgets and consulting project flow.
- Rebranding from BGB Group to BGBx risks client confusion and internal execution drag.
- If Kx Advisors or Hayden integration stalls, competitors poach strategic accounts quickly.
What makes BGBx unique
- June 2026 BGBx unified consulting, communications, science, data, and technology under one brand.
- Kx Advisors and Hayden Consulting Group deepen market access and lifecycle strategy breadth.
- BGBx claims 3D science, integrating medical, data, and behavioral science for clients.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Hybrid Work Options
- Professional Development Budget